Results 231 to 240 of about 91,883 (290)
This study demonstrates that transcription factor androgen receptor (AR) directly binds the LF promoter, driving lactoferrin overexpression to promote ferritin (FTH1/FTL) upregulation and inhibit p53‐ALOX12‐mediated ferroptosis in prostate cancer. Lactoferrin could be a new potential therapeutic target in prostate cancer.
Can Liu +18 more
wiley +1 more source
The journey of maternal platelets through the utero-placental circulation: routes, interactions, and physiological implications. [PDF]
Forstner D +3 more
europepmc +1 more source
NETosis and pyroptosis of immune cells in sepsis. [PDF]
Kashif AM, Ouyang Y, Li Y, Pan B.
europepmc +1 more source
Folinic Acid Improves Healing of Diabetic Foot Ulcers. [PDF]
Hoke GD +5 more
europepmc +1 more source
Human tissue kallikrein 14 induces the expression of IL-6, IL-8, and CXCL1 in skin fibroblasts through protease-activated receptor 1 signaling. [PDF]
Sasiadek L +16 more
europepmc +1 more source
Role and regulation of kinases in age-related macular degeneration. [PDF]
Fang J, Huang Y, Li B, Du Y.
europepmc +1 more source
Proteinase-Activated Receptors
Proteinase-activated receptors (PARs) are a unique family of G-protein-coupled receptors (GPCRs) that are activated in response to serine proteinases. There are four PAR family members; PAR-1 through to PAR-4.
Anke Rattenholl +3 more
core +3 more sources
The therapeutic potential of proteinase-activated receptors in arthritis
Proteinase-activated receptors are a family of seven-transmembrane G-protein-coupled receptors. Activation of PARs is initiated through cleavage of the N-terminus, unmasking a tethered ligand that can then interact with the receptor and lead to its activation. PARs exhibit both anti- and pro-inflammatory properties, although recent evidence has pointed
McIntosh, Kathryn A +3 more
openaire +5 more sources

